News and Trends 14 May 2019 RNAi Therapy Smashes Solid Tumors in Preclinical Tests Developed by the UK biotech Celixir, a therapy based on silencing genes with RNA molecules in a process called RNAi has shrunk tumors by 50% in culture. Although there are lots of innovative cancer treatments in the market, such as CAR T-cell therapy for blood cancer, solid tumors remain difficult to tackle. For this reason, […] May 14, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 10 May 2019 This Biotech Destroys Cancer Proteins by Introducing Them to ‘Executioner’ Proteins Nestled in the biotech hub of Cambridge, UK, is Polyprox. Less than a year old, this company is developing a new class of protein-based drugs that could treat cancer by degrading key proteins in the cancer cell. Mission: Develop drugs that destroy proteins in cancer cells by recruiting executioner proteins, called ligases. Polyprox develops protein […] May 10, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2019 Schizophrenia Treatments Could be Tested and Personalized Using Patients’ Blood Scientists at the University of Cambridge have developed a way to screen treatments for schizophrenia on single cells from a patient’s blood sample, which could speed up drug discovery and help to personalize treatments for people with the condition. Around 21 million people worldwide suffer from schizophrenia, and this is likely to get worse with […] May 8, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 6 May 2019 Molecules in Bee Jelly Could Protect Whole Nests Against Viruses for Generations A research team has discovered that honeybees pass molecules of RNA to each other by sharing it in edible jelly, which could lead to vaccines that can stop generations of bees from dying from viral infections. Honeybees don’t just give us honey. As the dominant pollinators of lots of food crops, around a third of […] May 6, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 May 2019 Next-Generation CAR-T Therapy Shows Promise in Child’s Neuroblastoma Cell Medica’s next-generation CAR-T cell therapy has resulted in ‘extensive tumor regression’ in a child with high-risk neuroblastoma, one of the deadliest types of childhood cancer. Only available to cancer patients for the last couple of years, CAR-T cell therapy has had impressive results in treating patients for whom other available options do […] May 1, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 25 Apr 2019 UK Scientists Engineer Cell Membrane for Long-Lasting Cell Therapy Scientists at the University of Bristol, UK, have made a cell therapy that produces a glue-like hydrogel, which could make stem cells last for longer in the body and help wound healing in conditions such as type 2 diabetes. Cell therapies have a lot of potential for healing wounds and regenerating tissue, but they also […] April 25, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2019 Needle-Free Vaccine for Bubonic Plague to be Developed in the UK The UK biotech Enesi Pharma has joined forces with researchers from the University of Oxford to develop a vaccine for the bubonic plague that is simple to use and doesn’t require needles. Caused by the bacteria Yersinia pestis, the bubonic plague is infamous for having killed over 50 million Europeans in the Middle Ages. While […] April 10, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Apr 2019 AACR 2019: European Biotech Progresses in Fighting Cancer The American Association for Cancer Research (AACR) met up in Atlanta, USA, to showcase the newest advances in cancer treatment from around the world. Sit back as we give you a quick rundown of the most interesting presentations from European organizations working to improve the treatment of cancer. Clinical trials In the conference last […] April 8, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2019 Update: Two-Drug HIV Treatment Effective for up to Three Years Update (04/04/2019): ViiV Healthcare’s two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for up to three years in patients’ blood. In a clinical study, 513 HIV-infected people switched to daily pills of Juluca from their standard drug regimes, which included three or four different drugs. Juluca was effective at suppressing the virus for […] April 4, 2019 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 3 Apr 2019 UK Scientists Activate Stem Cells to Heal Corneal Injuries A group of researchers in the UK has developed a potential treatment for corneal injuries, such as those caused by chemical burns, by making surrounding tissue softer and letting stem cells regenerate damaged tissue. The cornea is a transparent tissue that is important for focusing light onto the retina and guarding entry into the eye. […] April 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Apr 2019 Cambridge Fund Raises €175M to Supercharge Local Life Sciences Ecosystem The UK venture capital fund Cambridge Innovation Capital, backed by the University of Cambridge, has raised €175M (£150M) to spend on life science and technology companies in the Cambridge area. The money will support the 25 companies in the fund’s portfolio, including the biotech Bicycle Therapeutics, whose peptide-toxin molecules are in clinical trials for the […] April 1, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 29 Mar 2019 Liquid Biopsy for Lung Cancer Gets €46M Boost Inivata has raised a €46M (£40M) Series B round that will further advance the commercialization of the company’s blood test for lung cancer as well as the development of new tests. Investors include Woodford patient Capital Trust, IP Group, Cambridge Innovation Capital, Johnson & Johnson Innovation and RT Ventures. Based in both the US and […] March 29, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email